HPV evidence resources
Explore the evidence repository, interactive maps and research documents supporting HPV vaccine delivery.
Repository & evidence maps
Living evidence repository and interactive maps
An easy-to-search living library and interactive maps of HPV vaccine delivery evidence from Low- and Middle-Income Countries.
Repository documents
Report: The methods used and results for this repository version.
Protocol: The scope, eligibility criteria and planned methods for maintaining the repository.
Earlier versions
Earlier versions
Living systematic reviews
Living systematic reviews answering priority questions facing HPV vaccine delivery decision-makers in Low- and Middle-Income Countries.
Summary The findings on one page, for decision-makers
Report The full review: methods, included studies and findings
Protocol The plan: the question, the methods and how the review is kept up to date
LSR 1
Detecting HPVv misinformation
Protocol
v0.1
December 2025
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
LSR 2
Addressing HPVv misinformation
Protocol
v0.1
December 2025
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
LSR 3+4
Assessing cost, performance and value for money of HPVv delivery strategies
Protocol
v1.0
June 2026
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
LSR 5
Leveraging traditional and religious leaders in HPVv delivery and demand generation activities
Key conclusions
Key conclusions
Some HPV vaccination programmes involving traditional and religious leaders reported favourable findings across awareness, attitudes, intentions, uptake and completion. Nevertheless, the lack of studies using appropriate counterfactuals means there is no basis for establishing a causal effect of leader engagement on these outcomes or on equity. Leader involvement appears potentially valuable for implementation, but stronger comparative studies are needed to establish its independent effectiveness.
8 included studies · 5 low- and middle-income countries: Cameroon, Nigeria, Ethiopia, South Africa and Bhutan
Summary
v1.0
October 2026
Report
v1.0
September 2026
Protocol
v2.0
September 2026
Earlier versions
Earlier versions
Protocol
v1.0
June 2026
LSR 6
Integrating other health services with HPVv delivery programmes
Protocol
v1.0
June 2026
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
LSR 7
Integrating HPVv into adolescent health service delivery
Protocol
v1.0
June 2026
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
LSR 8
Delivering HPVv through routine EPI contacts
Protocol
v1.0
June 2026
Earlier versions
Earlier versions
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Alive Newsletter
Stay connected to Alive
